AbbVie trims full-year profit forecast on higher R&D expenses

Test tubes are seen in front of a displayed Abbvie logo in this illustration

(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development expenses during the second quarter.

The company now expects adjusted profit between $10.57 and $10.97 per share, compared with $10.72 to $11.12 it previously expected.

Analysts on average were expecting full-year earnings of $10.97 per share, according to Refinitiv IBES data.

AbbVie also trimmed adjusted profit for the second quarter by $0.15 per share and expects to post adjusted profit of $2.75 to $2.85 per share.

The company is scheduled to report second-quarter results on July 27.

(Reporting by Khushi Mandowara in Bengaluru; Editing by Shweta Agarwal and Sriraj Kalluvila)

Ad: Save every day with Amazon Deals: Check out today's daily deals on Amazon.

Related posts

Spirit Christmas expands New Jersey holiday pop-ups with new 2025 locations including Toms River

Flight attendant age discrimination suit moves forward in New Jersey court against United Airlines

Judge tosses inmate’s civil rights suit against Gov. Murphy over confinement claims